SDZ 51641

Overview

SDZ 51641 is an orally active fatty acid oxidation inhibitor. By reducing fatty acid oxidation, SDZ 51641 deprives the gluconeogenesis process of required energy and cofactors, thereby lowering blood glucose levels in diabetic models. SDZ 51641 can be used in diabetes research.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Others | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Drug Intermediate

Product Information

• Catalog No.: HY-182438
• CAS No.: 91456-99-4
• Molecular Formula: C14H20O2
• Molecular Weight: 220.31
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source